Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis

Head and neck squamous cell carcinoma (HNSCC) development is a multistage process includes the normal, dysplasia and squamous cell carcinoma (SCC) stages. Recently, increasing evidence has suggested that the tumor microenvironment (TME) is an integral part of malignant transformation. Exploring certain key node genes in TME for future intervention in dysplasia to interrupt oral carcinogenesis was the primary goal of this research. To achieve this goal, systems biology approaches were first applied to the epithelia and fibroblasts collected at sequential stages in a 4-nitroquinoline-1-oxide (4NQO) - induced rat oral carcinogenesis model. Through bioinformatics network construction, IL-1β was identified as one of the key node genes in TME during carcinogenesis. Immunohistochemical staining of human and rat samples demonstrated that IL-1β expression patterns were parallel to the stages of malignant transformation. Silencing IL-1β with lentivirus-delivered shRNA significantly inhibited oral squamous cell carcinoma cell growth both in vivo and in vitro. Based on these findings, we hypothesized that IL-1β may be a chemoprevention target in TME during oral carcinogenesis. Therefore, we targeted IL-1 in the TME by oral mucosal injection of an IL-1 receptor antagonist in 4NQO rats. The results demonstrated that targeting IL-1 could interrupt oral carcinogenesis by reprogramming the TME.

• Publication year

  2016

• Venue

  Scientific Reports

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/srep20208PMID 26831400PMCID 4735323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction network analysis of differentially expressed genes and screening of cancer marker in the urine of patients with invasive bladder cancer.

  2015cited by this paper
• IL‐1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer

  2015cited by this paper
• Recombinant human interleukin-1 receptor antagonist reduces acute lethal toxicity and protects hematopoiesis from chemotoxicity in vivo.

  2013cited by this paper
• Microenvironmental regulation of tumor progression and metastasis

  2013cited by this paper
• Identification of eight candidate target genes of the recurrent 3p12–p14 loss in cervical cancer by integrative genomic profiling

  2013cited by this paper
• Accessories to the crime: functions of cells recruited to the tumor microenvironment.

  2012cited by this paper
• Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.

  2011cited by this paper
• Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Role of interleukin 1 beta in esophageal squamous cell carcinoma

  2011cited by this paper
• Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblasts

  2011cited by this paper
• Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma.

  2011cited by this paper
• Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification.

  2011cited by this paper
• Genome-wide analysis reveals the active roles of keratinocytes in oral mucosal adaptive immune response

  2011cited by this paper
• Successful Treatment of Castleman's Disease with Interleukin-1 Receptor Antagonist (Anakinra)

  2010cited by this paper
• Relation between proinflammatory mediators and epithelial-mesenchymal transition in head and neck squamous cell carcinoma.

  2010cited by this paper
• T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer

  2010cited by this paper
• Why not treat human cancer with interleukin-1 blockade?

  2010cited by this paper
• Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma

  2009cited by this paper
• Fibroblast Growth Factor Receptor 2–Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal Carcinoma

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.

  2009cited by this paper
• The tumour microenvironment as a target for chemoprevention

  2007cited by this paper
• Frequent mutation of p16CDKN2A exon 1 during rat tongue carcinogenesis induced by 4‐nitroquinoline‐1‐oxide

  2007cited by this paper
• Frequent mutation of p16(CDKN2A) exon 1 during rat tongue carcinogenesis induced by 4-nitroquinoline-1-oxide.

  2007cited by this paper
• Stromal myofibroblasts and malignant transformation in a 4NQO rat tongue carcinogenesis model.

  2007cited by this paper
• The role of interleukin 1 in growth and metastasis of human cancer xenografts.

  2006cited by this paper
• 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis.

  2006cited by this paper
• Interleukin-1 Receptor Antagonist Inhibits the Expression of Vascular Endothelial Growth Factor in Colorectal Carcinoma

  2005cited by this paper
• Friends or foes — bipolar effects of the tumour stroma in cancer

  2004cited by this paper
• Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.

  2003cited by this paper
• Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types

  year unknowncited by this paper

• Image segmentation-based analysis reveals correlation between IL-1RA overexpression and worse survival outcomes in oral squamous cell carcinoma

  2026cites this paper
• Cytokine Profiling in Oral Carcinogenesis: Interleukin-1β and Interleukin-8 Expression in Premalignant and Malignant Lesions

  2025cites this paper
• The Role of Inflammasomes in Chronic Oral Inflammatory Disease and Oral Cancer: A Narrative Review

  2025cites this paper
• Microbial oncogenesis: the impact of Fusobacterium nucleatum on oral cancer pathways

  2025cites this paper
• Interleukin-1β and cancer immune response.

  2025cites this paper
• LCP1 upregulation via EGFR signaling promotes oral cancer progression through the JAK2/STAT3/IL-1β axis

  2025cites this paper
• Prognostic Significance and Emerging Predictive Potential of Interleukin-1β Expression in Oncogene-Driven NSCLC

  2025cites this paper
• Sulfasalazine combined with anti-IL-1β mAb induces ferroptosis and immune modulation in oral squamous cell carcinoma

  2025cites this paper
• Systemic Inflammatory Markers as Prognostic Factors in Oral Squamous Cell Carcinoma of the Tongue

  2025cites this paper
• The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes

  2025cites this paper
• Exploration of the role of AIM2/IL-1β in adult laryngeal papilloma

  2025cites this paper
• The Osgin Gene Family: Underexplored Yet Essential Mediators of Oxidative Stress

  2025cites this paper
• Genetically predicted circulating levels of cytokines and the risk of oral cavity and pharyngeal cancer: a bidirectional mendelian-randomization study

  2024cites this paper
• Immunotherapy in Oral Cancer

  2024cites this paper
• The interplay between microbiome and host factors in pathogenesis and therapy of head and neck cancer.

  2024cites this paper
• Diagnostic potential of salivary IL-1β, IL-8, SAT, S100P, and OAZ1 in oral squamous cell carcinoma, oral submucous fibrosis, and oral lichen planus based on findings from a Sri Lankan cohort

  2024cites this paper
• Anti‐VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis

  2024cites this paper
• Blocking β2-AR and Inhibiting COX-2: A Promising Approach to Suppress OSCC Development

  2024cites this paper
• Neuroimmune cell interactions and chronic infections in oral cancers

  2024cites this paper
• Single‐cell analysis of tumor microenvironment and cell adhesion reveals that interleukin‐1 beta promotes cancer cell proliferation in breast cancer

  2024cites this paper
• Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review

  2024cites this paper
• Proteomic analysis of holocarboxylase synthetase deficient-MDA-MB-231 breast cancer cells revealed the biochemical changes associated with cell death, impaired growth signaling, and metabolism

  2024cites this paper
• Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti‐PDL1 efficacy in head and neck cancer

  2023cites this paper
• Progress of peripheral blood immunoinflammatory markers in oral squamous cell carcinoma

  2023cites this paper
• Chronic oxidative stress adaptation in head and neck cancer cells generates slow-cyclers with decreased tumour growth in vivo

  2023cites this paper
• The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma

  2023cites this paper
• Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas.

  2023cites this paper
• IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH

  2023cites this paper
• Exosomes Regulate NLRP3 Inflammasome in Diseases

  2022cites this paper
• Inflammation, Immune Senescence, and Dysregulated Immune Regulation in the Elderly

  2022cites this paper
• An In Vitro Approach for Investigating the Safety of Lipotransfer after Breast-Conserving Therapy

  2022cites this paper
• Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer

  2022cites this paper
• What role does pyroptosis play in cancer?

  2022cites this paper
• The Assessment of Serum Cytokines in Oral Squamous Cell Carcinoma Patients: An Observational Prospective Controlled Study

  2022cites this paper
• Influence of conditioned medium from squamous cell carcinoma of the tongue on lymphoblasts and peripheral blood mononuclear cells.

  2022cites this paper
• Cytokines/chemokines and soluble immune checkpoint molecules in anti-GABAB receptor encephalitis.

  2022cites this paper
• Detection of IL1β Gene in Sudanese Patients with Gliomas Tumor in Khartoum state, Sudan

  2022cites this paper
• Inflammasomes as therapeutic targets in human diseases

  2021cites this paper
• The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation

  2021cites this paper
• Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment

  2021cites this paper
• Simultaneous Expression of Th1- and Treg-Associated Chemokine Genes and CD4+, CD8+, and Foxp3+ Cells in the Premalignant Lesions of 4NQO-Induced Mouse Tongue Tumorigenesis

  2021cites this paper
• Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders

  2021cites this paper
• Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential

  2021cites this paper
• The Role of Dectin-1 Signaling in Altering Tumor Immune Microenvironment in the Context of Aging

  2021cites this paper
• Increased Abundance of Tumour-Associated Neutrophils in HPV-Negative Compared to HPV-Positive Oropharyngeal Squamous Cell Carcinoma Is Mediated by IL-1R Signalling

  2021cites this paper
• P2 purinergic receptor signaling and interleukin-1 synergistically induce interleukin-6 production in a human oral squamous carcinoma cell line.

  2021cites this paper
• The role of icIL-1RA in keratinocyte senescence and development of the senescence-associated secretory phenotype

  2021cites this paper
• Expression of Interleukin-1ß and Interleukin-8 in Oral Potentially Malignant Disorders and Carcinomas

  2021influential citation
• Role of pyroptosis in cancer and its therapeutic regulation.

  2021cites this paper
• IL-1/IL-1R Signaling in Head and Neck Cancer

  2021influential citation
• Carcinoma de células escamosas cutâneo em cães

  2021cites this paper
• Interleukin-1β and Cancer

  2020cites this paper
• RalB degradation by dihydroartemisinin induces autophagy and IFI16/caspase-1 inflammasome depression in the human laryngeal squamous cell carcinoma

  2020cites this paper
• Role of exosomal miR‑21 in the tumor microenvironment and osteosarcoma tumorigenesis and progression (Review).

  2020cites this paper
• Combination of β2-AR Blocker and COX-2 Inhibitor Suppresses Development of Oral Squamous Cell Carcinoma

  2020cites this paper
• Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma

  2020cites this paper
• Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer

  2020cites this paper
• The role of icIL-1RA type 1 in oral keratinocyte senescence and the development of the senescence associated secretory phenotype

  2020cites this paper
• NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis

  2019cites this paper
• Tumor cells hijack enteric glia to activate colon cancer stem cells and stimulate tumorigenesis

  2019cites this paper
• Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers

  2018cites this paper
• Tumor microenvironment - Unknown niche with powerful therapeutic potential.

  2018cites this paper
• Metabolic reprogramming of the tumor microenvironment by p62 and its partners.

  2018cites this paper
• Proteomics-based investigation of multiple stages of OSCC development indicates that the inhibition of Trx-1 delays oral malignant transformation

  2018influential citation
• Interleukin-1 signaling contributes to the anti-tumor efficacy of Cetuximab in head and neck squamous cell carcinoma

  2018cites this paper
• Role of the NLRP3 inflammasome in cancer

  2018cites this paper
• The IL‐1/IL‐1R axis induces greater fibroblast‐derived chemokine release in human papillomavirus‐negative compared to positive oropharyngeal cancer

  2018cites this paper
• IL‐1&bgr; maintains the redox balance by regulating glutaredoxin 1 expression during oral carcinogenesis

  2017cites this paper
• Gene expression profiles and protein-protein interaction networks during tongue carcinogenesis in the tumor microenvironment

  2017influential citation
• Divisive influence of interleukin-1 receptor antagonist polymorphisms in melanoma patients

  2017cites this paper
• Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia

  2017cites this paper
• 3q26‐29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes

  2017cites this paper
• Stromal-epithelial lactate shuttle induced by tumor-derived interleukin-1β promotes cell proliferation in oral squamous cell carcinoma

  2017influential citation